基本信息
views: 249
Career Trajectory
Bio
Dr. Miller’s clinical and research interests focus on retinal disorders, including age related macular degeneration (AMD), diabetic eye disease, and macular telangiectasia (MacTel). She and her colleagues at Mass Eye and Ear pioneered the development of photodynamic therapy (PDT) using verteporfin (Visudyne®), the first pharmacologic therapy for AMD. Dr. Miller also identified the role of vascular endothelial growth factor (VEGF) in ocular neovascularization, forming the scientific basis of current antiangiogenic therapies for intraocular vascular diseases (including neovascular AMD and diabetic eye disease). Dr. Miller continues investigations to elucidate the pathophysiology of vision loss and improve therapies for retinal diseases.
Research Interests
Papers共 858 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
JOURNAL OF AAPOSno. 1 (2024): 103817-103817
The British journal of ophthalmologypp.bjo-2023, (2024)
Ophthalmology Sciencepp.100542, (2024)
Ophthalmology. Glaucomano. 4 (2024): 335-344
AMERICAN JOURNAL OF OPHTHALMOLOGY (2024): 194-204
PloS oneno. 5 (2024): e0304894-e0304894
Ophthalmology Glaucoma (2024)
OPHTHALMOLOGY SCIENCEno. 1 (2024): 100352-100352
crossref(2024)
Load More
Author Statistics
#Papers: 872
#Citation: 39357
H-Index: 90
G-Index: 179
Sociability: 8
Diversity: 1
Activity: 5
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn